EDUARDO
DÍAZ-RUBIO GARCÍA
Ikertzailea 2020-(e)ra arte
Hospital Universitario de Donostia
San Sebastián, EspañaHospital Universitario de Donostia-ko ikertzaileekin lankidetzan egindako argitalpenak (4)
2023
2021
2012
-
First-Line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: The phase III MACRO TTD study
Onkologie, Vol. 6, Núm. 2, pp. 96-103
-
First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: The phase III MACRO TTD study
Oncologist, Vol. 17, Núm. 1, pp. 15-25